Literature DB >> 18067521

Endothelial nitric oxide synthase gene polymorphism and elite endurance athlete status: the Genathlete study.

B Wolfarth1, T Rankinen, S Mühlbauer, M Ducke, R Rauramaa, M R Boulay, L Pérusse, C Bouchard.   

Abstract

In the Genathlete study, we examined the contribution of three polymorphisms in the endothelial nitric oxide synthase (NOS3) gene to discriminate elite endurance athletes (EEA) from sedentary controls (SC). The EEA group included a total of 316 Caucasian males with a VO2max >75 mL/kg. The SC group comprised 299 unrelated sedentary Caucasian males who had VO2max values below 50 mL/kg. The polymerase chain reaction technique was used to amplify a microsatellite (CA)(n) repeat in intron 13, a 27 bp repeat in intron 4 and a third fragment in exon 7 containing the Glu298Asp SNP. No difference was found between the EEA and SC groups for the 27 bp repeat and the Glu298Asp polymorphism. Chi-square analysis of the overall allelic distribution of the (CA)(n) repeat revealed no significant difference between the two groups (P=0.135). However, comparing carriers and non-carriers for the most common (CA)(n) repeat alleles, we found significant differences between SC and EEA, with more EEA subjects carrying the 164 bp allele (P=0.007). In summary, we found suggestive evidence that the 164 bp allele of the (CA)(n) repeat in intron 13 is associated with EEA status and may account for some of the differences between EEA and SC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18067521     DOI: 10.1111/j.1600-0838.2007.00717.x

Source DB:  PubMed          Journal:  Scand J Med Sci Sports        ISSN: 0905-7188            Impact factor:   4.221


  6 in total

1.  The -786 T/C polymorphism of the NOS3 gene is associated with elite performance in power sports.

Authors:  Félix Gómez-Gallego; Jonatan R Ruiz; Amaya Buxens; Marta Artieda; David Arteta; Catalina Santiago; Gabriel Rodríguez-Romo; José I Lao; Alejandro Lucia
Journal:  Eur J Appl Physiol       Date:  2009-08-22       Impact factor: 3.078

2.  Genes and Elite Marathon Running Performance: A Systematic Review.

Authors:  Hannah J Moir; Rachael Kemp; Dirk Folkerts; Owen Spendiff; Cristina Pavlidis; Elizabeth Opara
Journal:  J Sports Sci Med       Date:  2019-08-01       Impact factor: 2.988

3.  Right Ventricular Adaptation Is Associated with the Glu298Asp Variant of the NOS3 Gene in Elite Athletes.

Authors:  Zsolt Szelid; Árpád Lux; Márton Kolossváry; Attila Tóth; Hajnalka Vágó; Zsuzsanna Lendvai; Loretta Kiss; Pál Maurovich-Horvat; Zsolt Bagyura; Béla Merkely
Journal:  PLoS One       Date:  2015-10-30       Impact factor: 3.240

4.  Polygenic study of endurance-associated genetic markers ACE I/D, ACTN3 Arg(R)577Ter(X), CKMM A/G NcoI and eNOS Glu(G)298Asp(T) in male Gorkha soldiers.

Authors:  Seema Malhotra; Kiran Preet; Arvind Tomar; Shweta Rawat; Sayar Singh; Inderjeet Singh; L Robert Varte; Tirthankar Chatterjee; M S Pal; Soma Sarkar
Journal:  Sports Med Open       Date:  2017-04-26

5.  Polygenic Study of Endurance-Associated Genetic Markers NOS3 (Glu298Asp), BDKRB2 (-9/+9), UCP2 (Ala55Val), AMPD1 (Gln45Ter) and ACE (I/D) in Polish Male Half Marathoners.

Authors:  Piotr Gronek; Joanna Gronek; Ewelina Lulińska-Kuklik; Michał Spieszny; Marta Niewczas; Mariusz Kaczmarczyk; Miroslav Petr; Patricia Fischerova; Ildus I Ahmetov; Piotr Żmijewski
Journal:  J Hum Kinet       Date:  2018-10-15       Impact factor: 2.193

6.  No Evidence of a Common DNA Variant Profile Specific to World Class Endurance Athletes.

Authors:  Tuomo Rankinen; Noriyuki Fuku; Bernd Wolfarth; Guan Wang; Mark A Sarzynski; Dmitry G Alexeev; Ildus I Ahmetov; Marcel R Boulay; Pawel Cieszczyk; Nir Eynon; Maxim L Filipenko; Fleur C Garton; Edward V Generozov; Vadim M Govorun; Peter J Houweling; Takashi Kawahara; Elena S Kostryukova; Nickolay A Kulemin; Andrey K Larin; Agnieszka Maciejewska-Karłowska; Motohiko Miyachi; Carlos A Muniesa; Haruka Murakami; Elena A Ospanova; Sandosh Padmanabhan; Alexander V Pavlenko; Olga N Pyankova; Catalina Santiago; Marek Sawczuk; Robert A Scott; Vladimir V Uyba; Thomas Yvert; Louis Perusse; Sujoy Ghosh; Rainer Rauramaa; Kathryn N North; Alejandro Lucia; Yannis Pitsiladis; Claude Bouchard
Journal:  PLoS One       Date:  2016-01-29       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.